Oncotype DX breast cancer testing
Ended Awarded Last action
- Contract number
- FE02
- Awardee
-
Genomic Health, Inc. UEI RHN3L7SBF7J6
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $97,050
Award facts
- Contract value 100% obligated
- $97,050.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract FE02?
FE02 was awarded to Genomic Health, Inc. by Bureau of Medicine and Surgery (Department of the Navy) on June 1, 2008.
How much is contract FE02 worth?
The government has obligated $97,050 on FE02.
Is contract FE02 an order under another contract?
Yes. FE02 is a delivery order under N0018907DZ007, an indefinite delivery contract.
Was contract FE02 competed?
The extent of competition for FE02 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award